Strand, BioHealth Partner to Expand Sequencing-based Diagnostic Services to US | GenomeWeb

NEW YORK (GenomeWeb News) – Strand Genomics and BioHealth Innovation today announced a strategic partnership to expand the Strand Centers for Genomics and Personalized Medicine into the US.

As part of the deal, BHI will connect Strand with "key" market channels, providing patients and healthcare providers with access to genomic services. Based in Rockville, Md., BHI describes itself as an "innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.